Biodegradable andrographolide-eluting nanofibrous membranes for the treatment of cervical cancer

Yi-Pin Chen,1,2 Yen-Wei Liu,3 Demei Lee,3 Jiantai Timothy Qiu,4,5 Tzung-Yan Lee,6,7 Shih-Jung Liu3,8 1Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan; 2Department of Obstetrics and Gynecology, Keelung Chang Gung Memorial Hospital, Keelun...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chen YP, Liu YW, Lee D, Qiu JT, Lee TY, Liu SJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	andrographolide cervical cancer biodegradable nanofiber sustainable release Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/ee49c1b67b334cdfb1108cb9de8a4964
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ee49c1b67b334cdfb1108cb9de8a4964
record_format	dspace
spelling	oai:doaj.org-article:ee49c1b67b334cdfb1108cb9de8a49642021-12-02T07:17:31ZBiodegradable andrographolide-eluting nanofibrous membranes for the treatment of cervical cancer1178-2013https://doaj.org/article/ee49c1b67b334cdfb1108cb9de8a49642019-01-01T00:00:00Zhttps://www.dovepress.com/biodegradable-andrographolide-eluting-nanofibrous-membranes-for-the-tr-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yi-Pin Chen,1,2 Yen-Wei Liu,3 Demei Lee,3 Jiantai Timothy Qiu,4,5 Tzung-Yan Lee,6,7 Shih-Jung Liu3,8 1Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan; 2Department of Obstetrics and Gynecology, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan; 3Department of Mechanical Engineering, Chang Gung University, Tao-Yuan, Taiwan; 4Department of Obstetrics and Gynecology, Linkou Chang Gung Memorial Hospital, Tao-Yuan, Taiwan; 5Department of Biomedical Sciences, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan; 6Graduate Institute of Traditional Chinese Medicine, School of Chinese Medicine, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan; 7Department of Traditional Chinese Medicine, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan; 8Department of Orthopedic Surgery, Linkou Chang Gung Memorial Hospital, Tao-Yuan, Taiwan Background: In this study, we developed biodegradable andrographolide (AG)-eluting nanofibrous mats and evaluated their efficacy in treating cervical cancer. Materials and methods: Membranes of two different poly[(D,L)-lactide-co-glycolide] (PLGA)-to-AG ratios (6:1 and 3:1) were prepared via electrospinning technology. The liberation behavior of AG was evaluated. A cervical cancer model with C57BL/6J mice was created and employed for an in vivo efficacy assessment of the drug-eluting nanofibers. Twelve mice with cervical cancer were stochastically divided into three different groups (four animals per group): group A received no treatment as the control, group B was treated with pure PLGA mats, and group C was treated with AG-loaded nanofibrous membranes. The changes in tumor sizes were recorded. Results: All membranes eluted high concentrations of AG at the target area for three weeks, while the systemic drug concentration in the blood remained low. Histological analysis showed no obvious tissue inflammation. Compared with the mice in groups A and B, the tumor size of the mice in group C decreased with time until day 25, when the daily drug concentration reduced to 3 µg/mL. Conclusion: Biodegradable nanofibers with a sustainable release of AG exhibit adequate efficacy and durability for the treatment of mice with cervical cancer. Keywords: andrographolide, cervical cancer, biodegradable nanofiber, sustainable releaseChen YPLiu YWLee DQiu JTLee TYLiu SJDove Medical Pressarticleandrographolidecervical cancerbiodegradable nanofibersustainable releaseMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 421-429 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	andrographolide cervical cancer biodegradable nanofiber sustainable release Medicine (General) R5-920
spellingShingle	andrographolide cervical cancer biodegradable nanofiber sustainable release Medicine (General) R5-920 Chen YP Liu YW Lee D Qiu JT Lee TY Liu SJ Biodegradable andrographolide-eluting nanofibrous membranes for the treatment of cervical cancer
description	Yi-Pin Chen,1,2 Yen-Wei Liu,3 Demei Lee,3 Jiantai Timothy Qiu,4,5 Tzung-Yan Lee,6,7 Shih-Jung Liu3,8 1Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan; 2Department of Obstetrics and Gynecology, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan; 3Department of Mechanical Engineering, Chang Gung University, Tao-Yuan, Taiwan; 4Department of Obstetrics and Gynecology, Linkou Chang Gung Memorial Hospital, Tao-Yuan, Taiwan; 5Department of Biomedical Sciences, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan; 6Graduate Institute of Traditional Chinese Medicine, School of Chinese Medicine, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan; 7Department of Traditional Chinese Medicine, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan; 8Department of Orthopedic Surgery, Linkou Chang Gung Memorial Hospital, Tao-Yuan, Taiwan Background: In this study, we developed biodegradable andrographolide (AG)-eluting nanofibrous mats and evaluated their efficacy in treating cervical cancer. Materials and methods: Membranes of two different poly[(D,L)-lactide-co-glycolide] (PLGA)-to-AG ratios (6:1 and 3:1) were prepared via electrospinning technology. The liberation behavior of AG was evaluated. A cervical cancer model with C57BL/6J mice was created and employed for an in vivo efficacy assessment of the drug-eluting nanofibers. Twelve mice with cervical cancer were stochastically divided into three different groups (four animals per group): group A received no treatment as the control, group B was treated with pure PLGA mats, and group C was treated with AG-loaded nanofibrous membranes. The changes in tumor sizes were recorded. Results: All membranes eluted high concentrations of AG at the target area for three weeks, while the systemic drug concentration in the blood remained low. Histological analysis showed no obvious tissue inflammation. Compared with the mice in groups A and B, the tumor size of the mice in group C decreased with time until day 25, when the daily drug concentration reduced to 3 µg/mL. Conclusion: Biodegradable nanofibers with a sustainable release of AG exhibit adequate efficacy and durability for the treatment of mice with cervical cancer. Keywords: andrographolide, cervical cancer, biodegradable nanofiber, sustainable release
format	article
author	Chen YP Liu YW Lee D Qiu JT Lee TY Liu SJ
author_facet	Chen YP Liu YW Lee D Qiu JT Lee TY Liu SJ
author_sort	Chen YP
title	Biodegradable andrographolide-eluting nanofibrous membranes for the treatment of cervical cancer
title_short	Biodegradable andrographolide-eluting nanofibrous membranes for the treatment of cervical cancer
title_full	Biodegradable andrographolide-eluting nanofibrous membranes for the treatment of cervical cancer
title_fullStr	Biodegradable andrographolide-eluting nanofibrous membranes for the treatment of cervical cancer
title_full_unstemmed	Biodegradable andrographolide-eluting nanofibrous membranes for the treatment of cervical cancer
title_sort	biodegradable andrographolide-eluting nanofibrous membranes for the treatment of cervical cancer
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/ee49c1b67b334cdfb1108cb9de8a4964
work_keys_str_mv	AT chenyp biodegradableandrographolideelutingnanofibrousmembranesforthetreatmentofcervicalcancer AT liuyw biodegradableandrographolideelutingnanofibrousmembranesforthetreatmentofcervicalcancer AT leed biodegradableandrographolideelutingnanofibrousmembranesforthetreatmentofcervicalcancer AT qiujt biodegradableandrographolideelutingnanofibrousmembranesforthetreatmentofcervicalcancer AT leety biodegradableandrographolideelutingnanofibrousmembranesforthetreatmentofcervicalcancer AT liusj biodegradableandrographolideelutingnanofibrousmembranesforthetreatmentofcervicalcancer
_version_	1718399552847872000

Biodegradable andrographolide-eluting nanofibrous membranes for the treatment of cervical cancer

Ejemplares similares